Shape Therapeutics Inc.

Shape Therapeutics Inc.

Biotechnology Research

Seattle, Washington 11,108 followers

The future of programmable RNA Medicines

About us

ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Seattle, Washington
Type
Privately Held
Founded
2018
Specialties
Gene Editing, Gene Therapy, and RNA Editing

Locations

Employees at Shape Therapeutics Inc.

Updates

Similar pages

Browse jobs

Funding